Health Minister Sussan Ley has criticised pharmaceutical companies for dragging their feet on bringing new drugs to the Australian market and prioritising applying to lucrative markets overseas. “Australia has a world-class Pharmaceutical Benefits Scheme,” the Minister, who retained her portfolio in the weekend’s Cabinet reshuffle, says. “It is supported by world-class drug approval systems that
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.